Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer

K. Adzibolosu, Nicholas; B. Alvero, Ayesha; Ali‐Fehmi, Rouba; Gogoi, Radhika; Corey, Logan; Tedja, Roslyn; Chehade, Hussein; Gogoi, Vir; Morris, Robert; L. Anderson, Matthew; Vitko, Julie; Lam, Clarissa; B. Craig, Douglas; Drăghici, Sorin; Rutherford, Thomas; Mor, Gil

doi:10.3389/fimmu.2023.1204148

Public

Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer

Published in Frontiers in Immunology • Jun 26, 2023

Authors:

Nicholas K. Adzibolosu

Ayesha B. Alvero

Rouba Ali‐Fehmi

Abstract

Introduction: Ovarian cancer recurs in most High Grade Serous Ovarian Cancer (HGSOC) patients, including initial responders, after standard of care. To improve patient survival, we need to identify and understand the factors contributing to early or late recurrence and therapeutically target these m...

Subject

Chemotherapy

Medicine

Ovarian cancer

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!